Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. BMA
BMA logo

BMA Earnings

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Quarterly Results

BMA logo
BMA
FY2025Q3
2025-11-26 17:34:00
after hour
After Hours
Revenue
$863.55B
-4.09%
EPS
-$0.39
-158.21%
AI Prediction
-
AI Summary
BMA logo
BMA
FY2025Q2
2025-08-27 18:11:00
after hour
After Hours
Revenue
$877.30B
+3.47%
EPS
-$1.95
-2.01%
AI Prediction
-
AI Summary
BMA logo
BMA
2025-05-28 17:23:00
after hour
After Hours
Revenue
$775.28M
(est)
-
EPS
-$0.60
-63.67%
AI Prediction
-
AI Summary

BMA Earnings Forecast

Looking ahead, BMA remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2026/Q1 project quarter revenue of 1.01T and an EPS of 3.01K.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been unchanged by 0%, while EPS estimates have been unchanged by 0%. For the upcoming Q4 2025, revenue estimates have been adjusted unchanged by 0%. These revisions correlate with a -14.09% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in BMA long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
1Y
3Y
5Y
Currency: USD
Currency: USD
--
Revenue Estimate-:0
--
EPS Estimate-:0
—
Stock Price0
Revenue Estimates for FY2025
No Change
down
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
down
0.00%
In Past 3 Month
Revenue Estimates for Q4 2025
No Change
down
0.00%
In Past 3 Month
Stock Price
Go Down
down
-14.09%
In Past 3 Month

Earnings Forecast

Revenue
EPS
Currency: USD
Actual
Estimate
AI Analysis

Earnings Surprise Analysis

Revenue
EPS
1Y
3Y
AI Analysis
Earnings Reaction
The chart below shows how BMA performed 10 days before and after its earnings report, based on data from the past quarters. Typically, BMA sees a 4.41% change in stock price 10 days leading up to the earnings, and a 2.12% change 10 days following the report. On the earnings day itself, the stock moves by -0.23%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in SEP/2025, the stock changed 4.34% on the day following the earnings release and then changed by 8.81% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.

People Also Watch

Frequently Asked Questions

What were the key highlights of BMA's latest earnings report for FY2025Q3?

BMA reported its FY2025Q3 earnings on 2025-11-26, showcasing a revenue of 863.55B against an estimate of 900.40B, resulting in a -4.09% surprise. The EPS was -0.39, surpassing the expected 0.67 by -158.21%. The stock experienced a 4.34% price change on the earnings day and a 7.16% change over the next five days, reflecting market reactions to the results.

How did BMA's stock price react after the FY2025Q3 earnings release?

Following BMA's FY2025Q3 earnings announcement on 2025-11-26, the stock price moved by 4.34% on the day of the release. Over the subsequent five days, it saw a 7.16% change. Historically, BMA's stock price tends to shift by an average of 4.41% in the 10 days leading up to earnings and 2.12% in the 10 days following, providing insight into potential market.

What are the revenue and EPS estimates for BMA for 2026/Q1?

For 2026/Q1, analysts estimate BMA's annual revenue to reach 1.01T, while the EPS is projected at 3.01K. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

How does BMA's stock price correlate with earnings forecast revisions?

The correlation between BMA's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

What should investors expect from BMA's next earnings report?

Based on historical trends, BMA's stock price typically moves by 4.41% in the 10 days before its earnings and 2.12% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 3.01K and revenue of 1.01T.

What is the sentiment in Banco Macro SA (BMA) Q4 2025 Earnings Call Summary?

The earnings call reflects strong financial metrics, including a significant increase in loan growth and deposits, and an improvement in the commercial portfolio's NPL ratio. The Q&A highlights optimistic guidance on loan growth and sectors being financed, as well as a strategic acquisition. Despite some concerns about consumer portfolio deterioration and unclear management responses, the overall sentiment is positive. The bank's capital adequacy and proposed 100% dividend payout also contribute positively. Given the market cap, the stock is likely to see a positive reaction in the range of 2% to 8%.